These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. Isaacs E N Engl J Med; 2001 Aug; 345(6):466-7. PubMed ID: 11496864 [No Abstract] [Full Text] [Related]
9. Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy. Brzozowska A; Werner B J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):591-2. PubMed ID: 19877986 [No Abstract] [Full Text] [Related]
10. Citalopram and fluvoxamine in Tourette's disorder. Bajo S; Battaglia M; Pegna C; Bellodi L J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681 [No Abstract] [Full Text] [Related]
11. Extended-release fluvoxamine (Luvox CR). Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947 [No Abstract] [Full Text] [Related]
12. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine. Uguz F J Hum Lact; 2015 Aug; 31(3):371-3. PubMed ID: 25896469 [TBL] [Abstract][Full Text] [Related]
13. A display of hypomania in a depressed male in response to fluvoxamine. Horiguchi T; Sai S World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152 [TBL] [Abstract][Full Text] [Related]
14. Case of rapid bilateral cataract development in teenager using selective serotonin reuptake inhibitors. Kisilevsky E; Margolin EA Can J Ophthalmol; 2014 Oct; 49(5):e114-5. PubMed ID: 25284112 [No Abstract] [Full Text] [Related]
15. Seizure possibly associated with fluvoxamine. Kim KY; Craig JM; Hawley JM Ann Pharmacother; 2000 Nov; 34(11):1276-8. PubMed ID: 11098342 [TBL] [Abstract][Full Text] [Related]
16. Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy. Nafziger AN; Bertino JS; Goss-Bley AI; Kashuba AD J Clin Psychiatry; 1999 Mar; 60(3):187-90. PubMed ID: 10192595 [TBL] [Abstract][Full Text] [Related]
17. Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents. Reinblatt SP; DosReis S; Walkup JT; Riddle MA J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):119-26. PubMed ID: 19364290 [TBL] [Abstract][Full Text] [Related]
18. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. Gothelf D; Rubinstein M; Shemesh E; Miller O; Farbstein I; Klein A; Weizman A; Apter A; Yaniv I J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1258-62. PubMed ID: 16292117 [TBL] [Abstract][Full Text] [Related]
19. A case of pervasive developmental disorder complicated by social anxiety disorder responding well to fluvoxamine therapy. Yano H; Matsumoto H Tokai J Exp Clin Med; 2011 Jul; 36(2):44-6. PubMed ID: 21769772 [TBL] [Abstract][Full Text] [Related]
20. Aggravation of glaucoma with fluvoxamine. Jiménez-Jiménez FJ; Ortí-Pareja M; Zurdo JM Ann Pharmacother; 2001 Dec; 35(12):1565-6. PubMed ID: 11793621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]